Hepatitis B seropositive status in recipients or donors is not related to worse outcomes after haploidentical hematopoietic stem cell transplantation
Hepatitis B virus (HBV) has a high chronic infection rate in Asian population and limited studies are performed to analyze the impact of HBV seropositive recipients or donors in the condition of haploidentical hematopoietic stem cell transplantation (haplo-HSCT).
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Chunzi Yu, Yuqian Sun, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Jian Jin, Xiaojun Huang, Yu Wang Source Type: research
More News: Biology | Hematology | Hepatitis | Hepatitis B | Stem Cell Therapy | Stem Cells | Study | Transplants